<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><title>Canadian Cancer Survivor Network November Eletter</title><style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Georgia;
panose-1:2 4 5 2 5 4 5 2 3 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
h1
{mso-style-priority:9;
mso-style-link:"Heading 1 Char";
margin:0cm;
margin-bottom:.0001pt;
line-height:125%;
font-size:30.0pt;
font-family:"Helvetica","sans-serif";
color:#606060;
letter-spacing:-.75pt;
font-weight:bold;}
h2
{mso-style-priority:9;
mso-style-link:"Heading 2 Char";
margin:0cm;
margin-bottom:.0001pt;
line-height:125%;
font-size:19.5pt;
font-family:"Helvetica","sans-serif";
color:#404040;
letter-spacing:-.55pt;
font-weight:bold;}
h3
{mso-style-priority:9;
mso-style-link:"Heading 3 Char";
margin:0cm;
margin-bottom:.0001pt;
line-height:125%;
font-size:13.5pt;
font-family:"Helvetica","sans-serif";
color:#606060;
letter-spacing:-.4pt;
font-weight:bold;}
h4
{mso-style-priority:9;
mso-style-link:"Heading 4 Char";
margin:0cm;
margin-bottom:.0001pt;
line-height:125%;
font-size:12.0pt;
font-family:"Helvetica","sans-serif";
color:gray;
font-weight:bold;}
h5
{mso-style-priority:9;
mso-style-link:"Heading 5 Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:10.0pt;
font-family:"Times New Roman","serif";
font-weight:bold;}
h6
{mso-style-priority:9;
mso-style-link:"Heading 6 Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:7.5pt;
font-family:"Times New Roman","serif";
font-weight:bold;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-priority:9;
mso-style-link:"Heading 1";
font-family:"Cambria","serif";
color:#365F91;
font-weight:bold;}
span.Heading2Char
{mso-style-name:"Heading 2 Char";
mso-style-priority:9;
mso-style-link:"Heading 2";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;}
span.Heading3Char
{mso-style-name:"Heading 3 Char";
mso-style-priority:9;
mso-style-link:"Heading 3";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;}
span.Heading4Char
{mso-style-name:"Heading 4 Char";
mso-style-priority:9;
mso-style-link:"Heading 4";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;
font-style:italic;}
span.Heading5Char
{mso-style-name:"Heading 5 Char";
mso-style-priority:9;
mso-style-link:"Heading 5";
font-family:"Cambria","serif";
color:#243F60;}
span.Heading6Char
{mso-style-name:"Heading 6 Char";
mso-style-priority:9;
mso-style-link:"Heading 6";
font-family:"Cambria","serif";
color:#243F60;
font-style:italic;}
p.readmsgbody, li.readmsgbody, div.readmsgbody
{mso-style-name:readmsgbody;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.externalclass, li.externalclass, div.externalclass
{mso-style-name:externalclass;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.mcnimage, li.mcnimage, div.mcnimage
{mso-style-name:mcnimage;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.mcntextcontent, li.mcntextcontent, div.mcntextcontent
{mso-style-name:mcntextcontent;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.mcntextcontent1, li.mcntextcontent1, div.mcntextcontent1
{mso-style-name:mcntextcontent1;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
line-height:125%;
font-size:8.5pt;
font-family:"Helvetica","sans-serif";
color:#606060;}
p.mcntextcontent2, li.mcntextcontent2, div.mcntextcontent2
{mso-style-name:mcntextcontent2;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
line-height:150%;
font-size:11.5pt;
font-family:"Helvetica","sans-serif";
color:#606060;}
p.mcntextcontent3, li.mcntextcontent3, div.mcntextcontent3
{mso-style-name:mcntextcontent3;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
line-height:125%;
font-size:10.0pt;
font-family:"Helvetica","sans-serif";
color:#606060;}
p.mcntextcontent4, li.mcntextcontent4, div.mcntextcontent4
{mso-style-name:mcntextcontent4;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
line-height:150%;
font-size:11.5pt;
font-family:"Helvetica","sans-serif";
color:#606060;}
p.mcntextcontent5, li.mcntextcontent5, div.mcntextcontent5
{mso-style-name:mcntextcontent5;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
line-height:125%;
font-size:8.5pt;
font-family:"Helvetica","sans-serif";
color:#606060;}
span.org
{mso-style-name:org;}
span.locality
{mso-style-name:locality;}
span.region
{mso-style-name:region;}
span.postal-code
{mso-style-name:postal-code;}
span.EmailStyle39
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:65886705;
mso-list-template-ids:1739898544;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:36.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1
{mso-list-id:569576766;
mso-list-template-ids:1314920638;}
@list l1:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:36.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l2
{mso-list-id:1956255288;
mso-list-template-ids:958154768;}
@list l2:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:36.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
ol
{margin-bottom:0cm;}
ul
{margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1027" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body bgcolor="#F2F2F2" lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>See below for CCSN e-letter.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Thx.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Glen<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> Canadian Cancer Survivor Network [mailto:info=survivornet.ca@mail162.atl81.rsgsv.net] <b>On Behalf Of </b>Canadian Cancer Survivor Network<br><b>Sent:</b> November 3, 2015 12:11 PM<br><b>To:</b> glen.tolhurst@sympatico.ca<br><b>Subject:</b> Canadian Cancer Survivor Network November Eletter<o:p></o:p></span></p></div></div><p class=MsoNormal><o:p> </o:p></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;background:#F2F2F2;border-collapse:collapse'><tr><td width="100%" valign=top style='width:100.0%;padding:15.0pt 15.0pt 15.0pt 15.0pt'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=366 style='width:274.5pt;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 0cm 6.75pt 13.5pt'><p class=MsoNormal style='line-height:125%'><span style='font-size:8.5pt;line-height:125%;color:#606060'>Welcome to the Canadian Cancer Survivor Network's monthly newsletter!</span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=right width=197 style='width:147.75pt;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 0cm'><p class=MsoNormal style='line-height:125%'><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><a href="http://us8.campaign-archive2.com/?u=318d4e052fdd9593317146113&id=d6588341f9&e=79f909daf9" target="_blank"><span style='color:#606060'>View this email in your browser</span></a> <o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table></div></td></tr><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%' id=templateHeader><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='text-align:center'><a href="http://survivornet.us8.list-manage1.com/track/click?u=318d4e052fdd9593317146113&id=e9e325afb6&e=79f909daf9" target="_blank" title=""><span style='text-decoration:none'><img border=0 width=282 id="_x0000_i1025" src="http://gallery.mailchimp.com/318d4e052fdd9593317146113/images/24fd085a-1beb-44ce-ad4f-d6670f04e815.jpg"></span></a><o:p></o:p></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 6.75pt 6.75pt 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 6.75pt 0cm 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal><a href="http://survivornet.us8.list-manage1.com/track/click?u=318d4e052fdd9593317146113&id=43b24d821c&e=79f909daf9" target="_blank" title=""></a><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter" />
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0" />
<v:f eqn="sum @0 1 0" />
<v:f eqn="sum 0 0 @1" />
<v:f eqn="prod @2 1 2" />
<v:f eqn="prod @3 21600 pixelWidth" />
<v:f eqn="prod @3 21600 pixelHeight" />
<v:f eqn="sum @0 0 1" />
<v:f eqn="prod @6 1 2" />
<v:f eqn="prod @7 21600 pixelWidth" />
<v:f eqn="sum @8 21600 0" />
<v:f eqn="prod @7 21600 pixelHeight" />
<v:f eqn="sum @10 21600 0" />
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect" />
<o:lock v:ext="edit" aspectratio="t" />
</v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t75" alt="" href="http://survivornet.us8.list-manage1.com/track/click?u=318d4e052fdd9593317146113&id=43b24d821c&e=79f909daf9" target=""_blank"" title="""" style='position:absolute;margin-left:0;margin-top:0;width:423pt;height:149.25pt;z-index:251658240;mso-wrap-distance-left:0;mso-wrap-distance-top:0;mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;mso-position-horizontal:left;mso-position-horizontal-relative:text;mso-position-vertical-relative:line' o:allowoverlap="f" o:button="t">
<v:imagedata src="http://gallery.mailchimp.com/318d4e052fdd9593317146113/images/da673658-61a0-4ac5-bdf1-d8670276c4c6.jpg" />
<w:wrap type="square"/>
</v:shape><![endif]--><![if !vml]><a href="http://survivornet.us8.list-manage1.com/track/click?u=318d4e052fdd9593317146113&id=43b24d821c&e=79f909daf9" target=""_blank""><img border=0 width=564 height=199 src="http://gallery.mailchimp.com/318d4e052fdd9593317146113/images/da673658-61a0-4ac5-bdf1-d8670276c4c6.jpg" align=left title="""" v:shapes="_x0000_s1026"></a><![endif]><a href="http://survivornet.us8.list-manage1.com/track/click?u=318d4e052fdd9593317146113&id=43b24d821c&e=79f909daf9" target="_blank" title=""></a><o:p></o:p></p></td></tr></table></td></tr></table></td></tr></table></div></td></tr><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%' id=templateBody><tr><td width=200 valign=top style='width:150.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;background:white;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%' id=templateSidebar><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=right><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%' id=templateSidebarInner><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=203 style='width:152.25pt;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:125%'><strong><span style='font-size:13.5pt;line-height:125%;font-family:"Tahoma","sans-serif";color:purple'>In this issue...</span></strong><span style='font-size:10.0pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><ul type=disc><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l1 level1 lfo1;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif"'><a href="#melanoma" target="_self">M</a><a href="#melanoma">elanoma portal</a><o:p></o:p></span></li><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l1 level1 lfo1;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif"'><a href="#biologics" target="_self">Biologics & Biosimilars webinar</a><o:p></o:p></span></li><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l1 level1 lfo1;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif"'><a href="#louise" target="_self">Louise Binder joins CCSN</a><o:p></o:p></span></li><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l1 level1 lfo1;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif"'><a href="#seat_table" target="_self">A Seat at the Table</a><o:p></o:p></span></li><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l1 level1 lfo1;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif"'><a href="#youtube" target="_self">Watch our past webinars</a><o:p></o:p></span></li></ul></td></tr></table></td></tr></table></td></tr></table></div></td></tr></table></div></td><td width=390 valign=top style='width:292.5pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%' id=templateBodyInner><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:150%'><strong><span style='font-size:18.0pt;line-height:150%;font-family:"Tahoma","sans-serif";color:purple'>CCSN November 2015 Eletter</span></strong><span style='font-size:11.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'><br> <o:p></o:p></span></p><div><p class=MsoNormal style='line-height:150%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif";color:#606060'>The <a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=5ecf6ad301&e=79f909daf9" target="_blank"><span style='color:#6DC6DD'>Canadian Cancer Survivor Network</span></a> (CCSN) works to connect patients, survivors and other stakeholder groups with decision makers and the wider community to engage in discussion and to act on evidence-based best practices to alleviate the medical, emotional, financial and social costs of cancer. CCSN engages in and encourages research on ways to overcome barriers to optimal cancer care and follow-up for survivors in Canada.</span><span style='font-size:11.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'><o:p></o:p></span></p></div></td></tr></table></td></tr></table></td></tr></table></div></td></tr></table></div></td></tr><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%' id=templateFooter><tr><td valign=top style='padding:0cm 0cm 6.75pt 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:13.5pt 13.5pt 13.5pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #999999 1.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:200%'><a name=melanoma id=melanoma><strong><u><span style='font-size:16.5pt;line-height:200%;font-family:"Tahoma","sans-serif";color:purple;background:white'>Increased melanoma diagnoses basis for new melanoma portal</span></u></strong></a><span style='font-size:8.5pt;line-height:200%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:150%'><em><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif";color:#606060'>Ottawa - November 3, 2015</span></em><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif";color:#606060'>: The Canadian Cancer Survivor Network is pleased to announce the launch of its newest <a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=137bd79e58&e=79f909daf9" target="_blank">website portal on melanoma</a>.<br> <br>Approximately 6,500 Canadians are diagnosed with melanoma annually, and this number increases every year. For those dealing with this type of cancer, the journey from diagnosis to treatment and management of the disease is rarely a road travelled alone. Spouses, partners, children, extended family, friends and even colleagues may share in the burden of this life-changing disease.<br> <br>The Canadian Cancer Survivor Network (CCSN) recognized the heavy burden a diagnosis melanoma places not only on those who are diagnosed with it, but on their families and extended support networks. In response, CCSN has created an online portal recognizing and addressing the experience of melanoma, whether in its early or more advanced stages.<br> <br>"It is critically important to address the information needs and concerns of melanoma patients and their families,” said Jackie Manthorne, President and CEO of the Canadian Cancer Survivor Network. "Each patient will have his or her own experience of melanoma. Aside from purely medical considerations, the journey includes many practical decisions and adjustments. Each of these changes has the potential to impact those closest to them. Providing families and other caregivers a place to find reliable information they can relate to, and a place to connect, can help alleviate some of the anxiety associated with a melanoma diagnosis.”<br> <br><strong><span style='font-family:"Tahoma","sans-serif"'>About the Portal</span></strong><br> <br>The <em><span style='font-family:"Tahoma","sans-serif"'>Melanoma Portal </span></em>provides a trusted and accurate source of melanoma information – and connection. Like the spokes of a wheel, sections on the portal centralize information on the diagnosis and treatment of melanoma, provide information and resources on financial planning and address the issues that caregivers face.<br>The portal includes the following sections:</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p><ul type=disc><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l2 level1 lfo2;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif"'>About Melanoma</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif"'><o:p></o:p></span></li><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l2 level1 lfo2;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif"'>Prevention</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif"'><o:p></o:p></span></li><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l2 level1 lfo2;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif"'>Risk factors, Signs and Symptoms</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif"'><o:p></o:p></span></li><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l2 level1 lfo2;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif"'>Diagnosis</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif"'><o:p></o:p></span></li><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l2 level1 lfo2;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif"'>Treatment of Melanoma</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif"'><o:p></o:p></span></li><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l2 level1 lfo2;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif"'>Living Well with Melanoma</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif"'><o:p></o:p></span></li><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l2 level1 lfo2;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif"'>The Side-Effects of Treatment and Melanoma</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif"'><o:p></o:p></span></li><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l2 level1 lfo2;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif"'>Mental Wellness</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif"'><o:p></o:p></span></li><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l2 level1 lfo2;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif"'>Caregiving</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif"'><o:p></o:p></span></li><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l2 level1 lfo2;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif"'>Financial Information and Resources</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif"'><o:p></o:p></span></li></ul><p class=MsoNormal style='line-height:150%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif";color:#606060'>Social media platforms including a melanoma Twitter account, <a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=881e3036db&e=79f909daf9" target="_blank">@melanomacan</a> as well as the Canadian Cancer Survivor Network’s general Twitter account, <a href="http://survivornet.us8.list-manage1.com/track/click?u=318d4e052fdd9593317146113&id=a3d64c4f4e&e=79f909daf9" target="_blank">@survivornetca</a>.</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:13.5pt 13.5pt 13.5pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #999999 1.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:200%'><a name=biologics id=biologics><strong><u><span style='font-size:15.0pt;line-height:200%;font-family:"Tahoma","sans-serif";color:purple'>Free webinar: Biologics & Biosimilars</span></u></strong></a><span style='font-size:8.5pt;line-height:200%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 6.75pt 6.75pt 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 6.75pt 0cm 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=right style='border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal><a href="http://survivornet.us8.list-manage1.com/track/click?u=318d4e052fdd9593317146113&id=d1266e9dff&e=79f909daf9" target="_blank" title=""><span style='text-decoration:none'><img border=0 width=176 id="_x0000_i1026" src="https://gallery.mailchimp.com/318d4e052fdd9593317146113/images/f73b1779-62c3-4d81-9c75-765454462373.jpg"></span></a><o:p></o:p></p></td></tr></table><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=352 style='width:264.0pt;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:200%'><span style='font-size:10.5pt;line-height:200%;font-family:"Tahoma","sans-serif";color:#606060'>Our next webinar is titled: <em><span style='font-family:"Tahoma","sans-serif"'>What is a biosimilar? All you need to know about the current biologics and biosimilars landscape in Canada</span></em>, and will take place on <strong><span style='font-family:"Tahoma","sans-serif"'>Thursday, November 12th</span></strong> from <strong><span style='font-family:"Tahoma","sans-serif"'>1:30pm EDT - 2:30pm EST. </span></strong>This webinar will be presented by <strong><span style='font-family:"Tahoma","sans-serif"'>Karen Burke, Ph.D. </span></strong>of<strong><span style='font-family:"Tahoma","sans-serif"'> Amgen Canada, Inc. </span></strong></span><span style='font-size:8.5pt;line-height:200%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:150%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif";color:#606060'>The webinar is broken out into two parts:<br><br><strong><span style='font-family:"Tahoma","sans-serif"'>Part 1:</span></strong> <em><span style='font-family:"Tahoma","sans-serif"'>Biologics</span></em> - The first part of the presentation will focus on biologics, including an explanation of the high level of precision that is required to produce a consistent biological product each time.<br><br><strong><span style='font-family:"Tahoma","sans-serif"'>Part 2:</span></strong> <em><span style='font-family:"Tahoma","sans-serif"'>Biosimilars</span></em> – The second part of the presentation will focus on the growing interest in biosimilars, followed by what we can learn from Europe’s experience. We will also provide Health Canada’s position on biosimilars, discuss key issues surrounding biosimilars relevant to the Canadian market, as well as, the importance of patient safety and patient choice.<br><br>Following the presentation, there will be an interactive discussion where listeners will have an opportunity to ask questions and continue the dialogue on biologic medicines and biosimilars.</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 13.5pt 13.5pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='background:#843179;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:11.25pt 11.25pt 11.25pt 11.25pt;border-radius: 3px;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='text-align:center'><span style='font-family:"Arial","sans-serif"'><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=9279a2bbc1&e=79f909daf9" target="_blank" title="Click HERE to register for this webinar!"><b><span style='color:white;text-decoration:none'>Click HERE to register for this webinar!</span></b></a> <o:p></o:p></span></p></td></tr></table></div></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:13.5pt 13.5pt 13.5pt 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #999999 1.0pt;padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:200%'><a name=louise id=louise><strong><u><span style='font-size:16.5pt;line-height:200%;font-family:"Tahoma","sans-serif";color:purple'>Louise Binder Joins the CCSN Team!</span></u></strong></a><span style='font-size:8.5pt;line-height:200%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 6.75pt 6.75pt 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 6.75pt 0cm 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left style='border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal><img border=0 width=264 id="_x0000_i1027" src="https://gallery.mailchimp.com/318d4e052fdd9593317146113/images/adb6476f-ccc3-4116-809e-b346cecbfeba.jpg"><o:p></o:p></p></td></tr></table><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=right width=264 style='width:198.0pt;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:150%'><span style='font-size:15.0pt;line-height:150%;font-family:"Tahoma","sans-serif";color:#606060'>Louise Binder is a lawyer who has been involved in informing the development of health policy and systemic treatment access practices from a patient perspective for more than 20 years.</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:150%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif";color:#606060'>She started her work in this area in the HIV community in the early 1990s after her own diagnosis and before effective treatments were available for HIV. She cofounded the Canadian Treatment Action Council (CTAC) in 1996 that successfully ensured access to treatments and quality care for people living with HIV by working with the federal and provincial governments and other relevant stakeholders to enhance drug review and approval systems, pricing policies and access to liver transplants for this community. She wrote a paper on Universal Drug Coverage a decade ago while Chair of CTAC. She had a special interest in women's issues, chairing the Ontario women's organization Voice of Positive Women for over a decade. She has been involved in these issues internationally as well.<br><br>Two years ago Louise began similar work in the cancer area and we are happy to announce that Louise is now the <strong><span style='font-family:"Tahoma","sans-serif"'>Health Policy Consultant</span></strong> for the Canadian Cancer Survivor Network.<br><br>She has been recognized by many organizations for her work including receiving an Honorary Doctorate of Laws from her alma mater Queen's Law School, the Order of Ontario from the province of Ontario and two Queen Elizabeth II medals.</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:13.5pt 13.5pt 13.5pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #999999 1.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=600 style='width:450.0pt;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:200%'><a name="seat_table" id="seat table"><strong><u><span style='font-size:18.0pt;line-height:200%;font-family:"Tahoma","sans-serif";color:purple'>Join our Seat at the Table program!</span></u></strong></a><span style='font-size:8.5pt;line-height:200%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 6.75pt 6.75pt 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 6.75pt 0cm 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=right style='border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal><img border=0 width=264 id="_x0000_i1028" src="https://gallery.mailchimp.com/318d4e052fdd9593317146113/images/42934548-a590-4b86-8578-a41e023f18b2.jpg"><o:p></o:p></p></td></tr></table><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=264 style='width:198.0pt;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:150%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif";color:#606060'>The objective of A Seat at the Table is to increase the number of informed cancer patients, survivors and caregivers sitting on cancer and other health care Boards, committees and research peer review panels where decisions are being made about cancer diagnosis, treatment, post-treatment care and research funding.</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'><br><br></span><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif";color:#606060'>We are looking for volunteers to:</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><ul type=disc><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l0 level1 lfo3;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif"'>Become members of our Patient Engagement Advisory Committee to provide advice and guidance for our <em><span style='font-family:"Tahoma","sans-serif"'>A Seat at the Table</span></em> project.</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif"'><o:p></o:p></span></li><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l0 level1 lfo3;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif"'>Be nominated to sit on cancer and other healthcare Boards, committees and research peer review panels where decisions are being made about cancer care, including who will receive funding to conduct cancer research.</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif"'><o:p></o:p></span></li><li class=MsoNormal style='color:#606060;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l0 level1 lfo3;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif"'>Help us develop curriculum so that patients can be better informed about healthcare and cancer care issues.</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif"'><o:p></o:p></span></li></ul><p class=MsoNormal style='line-height:150%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif";color:#606060'>Please contact CCSN President & CEO Jackie Manthorne (<a href="mailto:jmanthorne@survivornet.ca" target="_blank">jmanthorne@survivornet.ca</a>) for the Committee’s terms of reference or to indicate your interest in being nominated to sit on Boards and committees. If you would like to help develop curriculum, please contact CCSN Board Secretary Mona Forrest (<a href="mailto:mforrest@survivornet.ca">mforrest@survivornet.ca</a>).</span><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:13.5pt 13.5pt 13.5pt 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #999999 1.0pt;padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:125%'><a name=youtube id=youtube><strong><u><span style='font-size:18.0pt;line-height:125%;font-family:"Tahoma","sans-serif";color:purple;background:white'>Watch past webinars on our YouTube channel!</span></u></strong></a><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 6.75pt 6.75pt 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 6.75pt 0cm 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=right style='border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal><img border=0 width=264 id="_x0000_i1029" src="https://gallery.mailchimp.com/318d4e052fdd9593317146113/images/13eb16d6-7dcc-43f8-ba23-5286bfc2c4fd.png"><o:p></o:p></p></td></tr></table><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=264 style='width:198.0pt;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:125%'><span style='font-size:11.5pt;line-height:125%;font-family:"Tahoma","sans-serif";color:#606060'>If you missed our webinars earlier this year, they are all available for viewing on our YouTube channel! Click on any webinar title below to start watching. Be sure to <strong><span style='font-family:"Tahoma","sans-serif"'><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=6d68cc1e88&e=79f909daf9" target="_blank"><span style='font-weight:normal'>subscribe to our channel</span></a></span></strong></span><strong><span style='font-size:11.5pt;line-height:125%;font-family:"Tahoma","sans-serif";color:blue'> </span></strong><span style='font-size:11.5pt;line-height:125%;font-family:"Tahoma","sans-serif";color:#606060'>to make sure you never miss another webinar from us! Stay tuned for information on upcoming webinars this year.</span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:125%'><span style='font-size:10.5pt;line-height:125%;font-family:"Tahoma","sans-serif";color:#606060'><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=41b3403321&e=79f909daf9" target="_blank">M</a><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=ee38f02a7e&e=79f909daf9">arijuana for Medical Purposes Regulations: What Do I Need to Know?</a><br>Presented by: Kaivan Talachian, CannTrust</span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br><br></span><span style='font-size:10.5pt;line-height:125%;font-family:"Tahoma","sans-serif";color:#606060'><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=336506e61f&e=79f909daf9" target="_blank">W</a><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=e586a5f9d7&e=79f909daf9">hat Chronic Disease Advocacy Can Offer Cancer Survivors</a><br>Presented by: Gerry Jeffcott/Rachael Manion, 3Sixty Public Affairs<br>Panelists: Gail Attara, Gastrointestinal Society; Shelagh Ross, Canadian Congenital Heart Alliance; Linda Wilhelm, Canadian Arthritis Patient Alliance</span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br><br></span><span style='font-size:10.5pt;line-height:125%;font-family:"Tahoma","sans-serif";color:#606060'><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=e055d2653f&e=79f909daf9" target="_blank">U</a><a href="http://survivornet.us8.list-manage1.com/track/click?u=318d4e052fdd9593317146113&id=6dabb49803&e=79f909daf9">nderstanding Your Health Insurance at Work</a><br>Presented by: Suzanne Lepage, Private Health Plan Specialist</span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br><br></span><span style='font-size:10.5pt;line-height:125%;font-family:"Tahoma","sans-serif";color:#606060'><a href="http://survivornet.us8.list-manage1.com/track/click?u=318d4e052fdd9593317146113&id=7eeb6bc14f&e=79f909daf9" target="_blank">Developing an Advocacy Plan</a></span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br></span><span style='font-size:10.5pt;line-height:125%;font-family:"Tahoma","sans-serif";color:#606060'>Presented by: Ryan Clarke, Advocacy Solutions</span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br><br></span><span style='font-size:10.5pt;line-height:125%;font-family:"Tahoma","sans-serif";color:#606060'><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=9164724309&e=79f909daf9" target="_blank">Federal Election - What Are the Parties Saying About Healthcare & Cancer?</a></span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br></span><span style='font-size:10.5pt;line-height:125%;font-family:"Tahoma","sans-serif";color:#606060'>Presented by: Gerry Jeffcott, 3Sixty Public Affairs<br>Panelists: Colleen Savage of the Cancer Advocacy Coalition of Canada and Kathy Barnard of the Save Your Skin Foundation</span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:13.5pt 13.5pt 13.5pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #999999 1.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=600 style='width:450.0pt;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:125%'><strong><span style='font-size:18.0pt;line-height:125%;font-family:"Tahoma","sans-serif";color:purple'>Follow CCSN on our social media pages!</span></strong><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:125%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><strong><span style='font-size:9.0pt;line-height:125%;font-family:"Tahoma","sans-serif";color:purple'>Twitter</span></strong><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br></span><span style='font-size:10.0pt;line-height:125%;font-family:"Tahoma","sans-serif";color:#606060'><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=6222a08260&e=79f909daf9" target="_blank">@survivornetca</a> - our main twitter account of information, news and resources on all cancers<br><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=f53e4c388e&e=79f909daf9" target="_blank">@bestbreastnews</a> - information on breast health and breast cancer<br><a href="http://survivornet.us8.list-manage2.com/track/click?u=318d4e052fdd9593317146113&id=7f776fa2be&e=79f909daf9" target="_blank">@prostatepost</a> - news, events and resources on prostate cancer<br><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=193662c1ad&e=79f909daf9" target="_blank">@canadianmeso</a> - details on asbestos and mesothelioma<br><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=5ea352452a&e=79f909daf9" target="_blank">@LungCancerCan</a> - focuses on lung cancer news, events and awareness<br><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=13c68bf87c&e=79f909daf9" target="_blank">@CCSNpoli</a> - general, non-partisan talk about the politics of healthcare and cancer care<br><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=24c9874e04&e=79f909daf9" target="_blank">@MedMarijuanaCan</a> - news and information regarding medical marijuana<br><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=b2717e4e9a&e=79f909daf9" target="_blank">@s</a><a href="http://survivornet.us8.list-manage2.com/track/click?u=318d4e052fdd9593317146113&id=59865b8840&e=79f909daf9">tomachcancerca</a> - information and resources on stomach cancer <br><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=9650b1ed84&e=79f909daf9" target="_blank">@</a><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=2980740d57&e=79f909daf9">cervicalcanca</a> - information and resources on cervical cancer<br><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=2632a42fa2&e=79f909daf9" target="_blank">@</a><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=4144b7f7c6&e=79f909daf9">melanomacan</a> - information and resources on melanoma</span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br> <o:p></o:p></span></p><p class=MsoNormal style='line-height:125%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><strong><span style='font-size:9.0pt;line-height:125%;font-family:"Tahoma","sans-serif";color:purple'>Facebook</span></strong><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br></span><span style='font-size:9.0pt;line-height:125%;font-family:"Tahoma","sans-serif";color:#606060'><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=745768dc3c&e=79f909daf9" target="_blank">Click here to 'like' us on Facebook!</a><br>Pages dedicated to <a href="http://survivornet.us8.list-manage1.com/track/click?u=318d4e052fdd9593317146113&id=d24a7327df&e=79f909daf9" target="_blank">asbestos and mesothelioma</a> and <a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=1d74bdbc4c&e=79f909daf9" target="_blank">prostate cancer!</a></span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><o:p></o:p></span></p><p class=MsoNormal style='line-height:125%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br></span><strong><span style='font-size:9.0pt;line-height:125%;font-family:"Tahoma","sans-serif";color:purple'>YouTube</span></strong><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br></span><span style='font-size:13.0pt;line-height:125%;font-family:"Georgia","serif";color:#606060'><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=b2b25bc3cf&e=79f909daf9" target="_blank"><span style='font-size:9.0pt;line-height:125%;font-family:"Tahoma","sans-serif"'>Access all of our recorded webinars & other video content!</span></a></span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br> <o:p></o:p></span></p><p class=MsoNormal style='line-height:125%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><strong><span style='font-size:9.0pt;line-height:125%;font-family:"Tahoma","sans-serif";color:purple'>Slideshare</span></strong><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=f793d86ba0&e=79f909daf9" target="_blank"><span style='font-size:9.0pt;line-height:125%;font-family:"Tahoma","sans-serif"'>Click here to follow our slideshare page!</span></a><br><br></span><strong><span style='font-size:9.0pt;line-height:125%;font-family:"Tahoma","sans-serif";color:purple'>Pinterest</span></strong><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br></span><span style='font-size:9.0pt;line-height:125%;font-family:"Tahoma","sans-serif";color:#606060'><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=721028a362&e=79f909daf9" target="_blank">Follow us on our Pinterest page!</a></span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><o:p></o:p></span></p><p class=MsoNormal style='line-height:125%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:13.0pt;line-height:125%;font-family:"Georgia","serif";color:#606060'> </span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><o:p></o:p></span></p><p class=MsoNormal style='line-height:125%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><strong><span style='font-size:9.0pt;line-height:125%;font-family:"Tahoma","sans-serif";color:purple'>Blog</span></strong><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br></span><span style='font-size:9.0pt;line-height:125%;font-family:"Tahoma","sans-serif";color:#606060'>Follow our main blog: <a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=b299088db8&e=79f909daf9" target="_blank">Jackie Manthorne's Cancer Blog</a><br>Follow our blog focused on asbestos and mesothelioma: <a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=ac43514e44&e=79f909daf9" target="_blank">Canadian Meso Blog</a></span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><o:p></o:p></span></p><p class=MsoNormal style='line-height:125%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br></span><strong><span style='font-size:9.0pt;line-height:125%;font-family:"Tahoma","sans-serif";color:purple'>Weekly newsletter</span></strong><span style='font-size:9.0pt;line-height:125%;font-family:"Tahoma","sans-serif";color:#606060'><br><a href="http://survivornet.us8.list-manage1.com/track/click?u=318d4e052fdd9593317146113&id=c0fbf9fdcf&e=79f909daf9" target="_blank">Click here to subscribe to our weekly newsletter!</a></span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:13.5pt 13.5pt 13.5pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #999999 1.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=600 style='width:450.0pt;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:125%'><em><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'>Copyright © 2015 Canadian Cancer Survivor Network, All rights reserved.</span></em><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br><br>You are receiving this email because you subscribed to it.<br><br><strong><span style='font-family:"Helvetica","sans-serif"'>Our mailing address is:</span></strong><o:p></o:p></span></p><div><p class=MsoNormal style='line-height:125%'><span class=org><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'>Canadian Cancer Survivor Network</span></span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><o:p></o:p></span></p><div><div><p class=MsoNormal style='line-height:125%'><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'>1750 Courtwood Crescent<o:p></o:p></span></p></div><div><p class=MsoNormal style='line-height:125%'><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'>Suite 210<o:p></o:p></span></p></div><p class=MsoNormal style='line-height:125%'><span class=locality><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'>Ottawa</span></span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'>, <span class=region>ON</span> <span class=postal-code>K2C 2B5</span> <o:p></o:p></span></p><div><p class=MsoNormal style='line-height:125%'><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'>Canada<o:p></o:p></span></p></div></div><p class=MsoNormal style='line-height:125%'><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br><a href="http://survivornet.us8.list-manage1.com/vcard?u=318d4e052fdd9593317146113&id=f2916c1a7e"><span style='color:#606060'>Add us to your address book</span></a><o:p></o:p></span></p></div><p class=MsoNormal style='margin-bottom:12.0pt;line-height:125%'><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br><br><a href="http://survivornet.us8.list-manage.com/unsubscribe?u=318d4e052fdd9593317146113&id=f2916c1a7e&e=79f909daf9&c=d6588341f9"><span style='color:#606060'>unsubscribe from this list</span></a> <a href="http://survivornet.us8.list-manage1.com/profile?u=318d4e052fdd9593317146113&id=f2916c1a7e&e=79f909daf9"><span style='color:#606060'>update subscription preferences</span></a> <o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table></div></td></tr></table></div></td></tr></table></div><p class=MsoNormal><img border=0 width=1 height=1 id="_x0000_i1030" src="http://survivornet.us8.list-manage.com/track/open.php?u=318d4e052fdd9593317146113&id=d6588341f9&e=79f909daf9"><o:p></o:p></p></div></body></html>